Serratia Chorioamnionitis and Culture Proven Sepsis in a Preterm Neonate: A Case Report and Review of the Literature

Pediatr Infect Dis J. 2021 Feb 1;40(2):e62-e65. doi: 10.1097/INF.0000000000002962.

Abstract

Background: Serratia marcescens is a well-known cause of nosocomial infectious outbreaks in the neonatal intensive care unit, with a high mortality rate in the vulnerable preterm population. However, it is not typically associated with neonatal sepsis secondary to intrapartum vertical transmission. We present the case of a preterm male born at 25 weeks and 4 days of gestation in Okinawa, Japan with culture-proven S. marcescens chorioamnionitis and sepsis, as well as a review of the previously published literature.

Methods: We conducted a literature search utilizing MeSH indexing with the headings [chorioamnionitis], [Serratia], and [infant, newborn] limited to "humans" with a publication date range between 1950 and 2020.

Results: All reported cases of preterm S. marcescens chorioamnionitis occurred in coastal locations. The majority of cases resulted in spontaneous abortion, and we found no published reports of confirmed S. marcescens chorioamnionitis in conjunction with viable preterm delivery and positive neonatal cultures. In the case presented herein, S. marcescens chorioamnionitis with associated neonatal sepsis was confirmed by positive placental and blood cultures. Bacterial clearance was achieved following an antibiotic course consisting of 5 days of gentamicin and 14 days of meropenem therapy.

Conclusions: S. marcescens is an uncommon cause of chorioamnionitis that can have devastating neonatal consequences, especially in the at-risk preterm population.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adult
  • Anti-Bacterial Agents / therapeutic use
  • Chorioamnionitis / drug therapy
  • Chorioamnionitis / microbiology*
  • Female
  • Humans
  • Infant, Newborn
  • Infant, Premature*
  • Male
  • Pregnancy
  • Sepsis / drug therapy
  • Sepsis / microbiology*
  • Serratia / isolation & purification*
  • Serratia Infections / drug therapy
  • Serratia Infections / microbiology*
  • Serratia Infections / pathology

Substances

  • Anti-Bacterial Agents